NEW YORK – Immuneering on Thursday said it signed a clinical supply agreement with Regeneron to obtain the anti-PD-1 therapy Libtayo (cemiplimab) for a Phase IIa trial testing Immuneering's MEK ...

CHANDIGARH: The 104 illegal immigrants deported from the United States have revealed a common link—most entered the US in ...